|
Case ID: 90 |
FVII:C% | Human | Rabbit | Unknown |
|---|---|---|---|---|
| 12 | ||||
| FVII:Ag% | 14 | |||
| Reported Clinical Severity | asymptomatic | |||
| Comments | FVII MALTA I & II | |||
| Reference | Alshinawi et al 1998 | Common Variant Sites tested and found to be as per the reference sequence in both alleles | ||
The details of the variants found in this patient are listed below
| Variant ID | No. of Cases | MAF* | Genotype | Type | Effect | Location in gene | Mutation (cDNA) | Sequence Context | Amino Acid | Protein Change | Domain | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HGVS | Legacy | |||||||||||
| 54 | 4 | Heterozygous | Point | Missense | Exon 7 | c.580C>A | CCA>ACA | 194 | 134 | p.Pro194Thr | Activation Peptide | |
| 80 | 38 | 0.000151 | Heterozygous | Point | Missense | Exon 9 | c.911C>T | GCG>GTG | 304 | 244 | p.Ala304Val | Serine Protease |
| 998 | 116 | 0.1341 | Heterozygous | Point | Missense | Exon 9 | c.1238G>A | CGG>CAG | 413 | 353 | p.Arg413Gln | Serine Protease |
| 999 | 64 | 0.1419 | Heterozygous | Point | Silent | Exon 6 | c.525C>T | CAC>CAT | 175 | 115 | p.His175= | EGF2 |